Osteoarthritis
-
Sports Medicine
Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ — Sparta Biomedical, a private medical device company focused on osteoarthritis repair solutions, today announced that…
Read More » -
Recon
HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis after ACL Revision Surgery
Randomized Clinical Trial to Explore the Efficacy of Concentrated Bone Marrow Aspirate as an Addition to ACL Revision Surgery NEW…
Read More » -
Recon
New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement
First Study to Demonstrate Longer-Term Benefits of Modern Hip Arthroscopy Techniques NEW YORK, April 18, 2024 /PRNewswire/ — A new study by surgeon-scientists…
Read More » -
Recon
Orthopedic Surgeon Tomas Pevny, MD, of Valley View, Is the First in the Roaring Fork Valley to Offer iovera°, a New Option to Manage Knee Pain
The iovera° Technology is a Non-Opioid Treatment Option to Help Patients Relieve the Chronic Pain of Osteoarthritis GLENWOOD SPRINGS, Colo., Feb.…
Read More » -
Recon
AAOS Updates Clinical Practice Guideline for the Management of Osteoarthritis of the Hip
Updated guideline offers the latest in evidence-based research to reduce pain, expand function and improve quality of life ROSEMONT, Ill. , Jan. 23, 2024 /PRNewswire/…
Read More » -
Biologics
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Recon
Stronger Thigh Muscles May Prevent Knee Replacement Surgery
CHICAGO, Nov. 27, 2023 /PRNewswire/ — Stronger quadriceps muscles, relative to the hamstrings, may lower the risk of total knee replacement, according…
Read More » -
Regulatory
ZKR Orthopedics announces FDA Breakthrough Device designation for the LIFT Implant Technology
KENTFIELD, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — ZKR Orthopedics, Inc., a clinical stage medical device company, today announced that…
Read More » -
Biologics
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study…
Read More » -
Recon
AAOS Updates Clinical Practice Guideline for Surgical Management of Osteoarthritis of the Knees
Updated guideline offers the latest in evidence-based research to improve surgical success and reduce complications and postoperative pain ROSEMONT, Ill., Jan.…
Read More » -
Sports Medicine
Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study
Implantable shock absorber demonstrates clinically meaningful pain relief and functional improvement in data presented at OSET September 23, 2022 FREMONT,…
Read More » -
Sports Medicine
Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis
August 16, 2022 FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Biologics
First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA
Ongoing trial to assess the potential of Zilosul™ to address unmet medical need in OA which affects more than 72 million…
Read More » -
Extremities
HSS Study Tackles Concomitant Limb Deformity, End-Stage Ankle OA
Elizabeth Hofheinz, M.P.H., M.Ed New work from Hospital for Special Surgery (HSS) in New York has looked at eight patients…
Read More »